Psyence Group (“Psyence”) has announced that it has closed the second tranche of its previously announced private placement of up to C$3m. The news comes just weeks after the first tranche was closed for gross proceeds of C$1.22m from a consortium led by Brandon Kerzner. The non-brokered private placement is subject to the approval of the CSE and will primarily be used to advance the Company’s upcoming Phase 2 palliative care trial, which is expected to commence before year end. In addition to t ....
14 Dec 2022
Psyence Group: Psyence closes second tranche of private placement and appoints strategic advisor ahead of trial
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Psyence Group: Psyence closes second tranche of private placement and appoints strategic advisor ahead of trial
Psyence Group Inc. (PSYG:CNQ) | 0 0 0.0%
- Published:
14 Dec 2022 -
Author:
Ryan Hampton | Alp Ergin -
Pages:
3
Psyence Group (“Psyence”) has announced that it has closed the second tranche of its previously announced private placement of up to C$3m. The news comes just weeks after the first tranche was closed for gross proceeds of C$1.22m from a consortium led by Brandon Kerzner. The non-brokered private placement is subject to the approval of the CSE and will primarily be used to advance the Company’s upcoming Phase 2 palliative care trial, which is expected to commence before year end. In addition to t ....